Hotline:
+ 49 (0) 2204 2918806

Market studies for category E

Items 1 to 10 of 127 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 13
  1. Net price*
    Year
  2. $6,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts

    GlobalData
    402 pages
    Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone. The global peripheral vascular ste
    Englisch | Zukunftsanalyse | SKU: 378465
  3. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Gastric Cancer Global Clinical Trials Review, H2, 2013

    GlobalData
    137 pages
    GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2013" provides data on the Gastric Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastric Cancer. It includes an overview of the trial numbers and their recruitment status as per
    Englisch | Zukunftsanalyse | SKU: 378531
  4. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Epratuzumab (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022

    GlobalData
    64 pages
    Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvement, known as lupus nephritis (LN). The term LN
    Englisch | Zukunftsanalyse | SKU: 378499
  5. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Postmenopausal Vaginal Atrophy - Italy Drug Forecast and Market Analysis to 2022

    GlobalData
    80 pages
    Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a considerable change between 2012 and 2022. This market has historically had a large untreated population due to: low diagnosis rates, safety issues with the existing therapies, and poor patient complianc
    Englisch | Zukunftsanalyse | SKU: 378563
  6. $3,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Renal Denervation - Current and Future Players

    GlobalData
    148 pages
    Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the di
    Englisch | Zukunftsanalyse | SKU: 378470
  7. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Uterine Cancer Global Clinical Trials Review, H2, 2013

    GlobalData
    140 pages
    GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2013" provides data on the Uterine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Cancer. It includes an overview of the trial numbers and their recruitment status as per
    Englisch | Zukunftsanalyse | SKU: 378536
  8. $250.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    TriOil Resources Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013

    GlobalData
    78 pages
    TriOil Resources Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, analysis and stra
    Englisch | Zukunftsanalyse | SKU: 233592
  9. $6,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Global Analysis and Market Forecasts

    GlobalData
    171 pages
    Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergenc
    Englisch | Zukunftsanalyse | SKU: 378504
  10. $4,450.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts

    GlobalData
    242 pages
    Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart’s rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the heart’s electrical system, and are related to cardiac dyssynch
    Englisch | Zukunftsanalyse | SKU: 378475
  11. $6,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Total Hip Replacement - Global Analysis and Market Forecasts

    GlobalData
    381 pages
    Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the primary indication for to
    Englisch | Zukunftsanalyse | SKU: 378541

Items 1 to 10 of 127 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 13